that is one of the key issues with IR: "Sooner or later,

New Post Public Reply Private Reply Replies (2) Message Board
thesmalls tradingjeff #14272
that is one of the key issues with IR:

"Sooner or later, everyone will be on Muse's sh!t list." any push back, follow up questions, requests for clarifications or anything that is perceived as the slightest slight and you get bounced from their rolls and directed to Bill. after of course they tell you to sell your shares and move on. i still dont see how alienating every, major, outside shareholder benefits the company in the short or long run? further, with their petty name calling and singling out individual shareholders, what does that say to remaining shareholders...? dont ask questions. dont cross us. or you maybe next. GREAT way to build rapport and trust. of course, when one goes down that path where ego tries to supplement competence - it often goes sideways.

still trying to decipher the barrage of tweets today. anyone care to expound on what they mean or what their intent was with respect to addressing the viability of owning shares in $TPAC vs trading MRVB picks...? are they saying buying TPAC today is or is not a good long term investment? more importantly - why are shareholder on here or any forum needing that type of clarification? it should be rather straight forward if trading at $0.0008 and they are standing behind a PPS of $0.01 in just a little over two months. seems like a no brainer. but then again, the market is not buying into one way or the other. vast majority of the action (what little there has been today) has again been on the sell side.

eventually IR/Muse may come to realize that shareholders can be a major asset in their own strategy. maybe the adversarial or condescending approach isnt the best suited for mutual goal achievement. maybe if their childish tweets and barely legible twitter rants were replaced with open dialogue with the full understanding that there IS going to be pushback (because that is what individual investors do to differentiate between dazzling with details and baffling with BS) then everyone would be on the same page and moving forward together. but then again, that was previously suggested and immediately mocked and criticized (not to mention blatantly lied about).

last point for the above - if IR is so glad to get those shares back - why dont they make a competitive offer to those shareholders who they want to sell? if they will be in such short supply - lock them up now before they get more expensive. if their PPS target is a lock - how about offering 1/2 or 1/3 of the target today?

ragz - you addressed briefly how the PPS gets to $0.01 by year end but you cited SLA that doesnt begin to 2017. even if they get production/revenues started in 2016 - what are payment terms where those monies could realistically hit TPACs balance sheet and be available for a buyback to shift supply/demand to move price forward? as daily average volume continues to drop - the amount the company can buy back each day declines as well.

guess we will know more tomorrow. will it be specific enough to bring in the new investors or stoke existing investors to resume buying? will it be enough to keep them buying or be just an out for those looking to leave on any sign of strength after the last 6 months of subterfuge?
2

Trans-Pacific Aerospace (TPAC) Stock Research Links

TPAC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles